Angelica M. Hernandez

FDA investigator · also recorded as Ayo Angelica M. Hernandez, Fol Angelica M. Hernandez

Appears on 15 documents from 2022 to 2026, most often at sites in India. Most often cites control of microbiological contamination (21 CFR 211.113).

15
Documents on file
5.1
Observations per 483
2022
First seen
2026
Most recent

What they cite most

From 74 observations

Activity by year

2022: 4, 2023: 1, 2024: 4, 2025: 4, 2026: 2

Where

India 6 · Puerto Rico 6 · France 1 · North Carolina 1

Is Angelica M. Hernandez coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

15 documents, newest first
FirmOpen
483 NEOLPHARMA, INCMar 10, 2026 · Caguas, Puerto Rico
483 Bristol-Myers Squibb Holdings Pharma Ltd. Liability CompanyFeb 13, 2026 · Manati, Puerto Rico
483 Gland Chemicals Private LimitedNov 27, 2025 · Chennai, India
483 EUGIA Pharma Specialities LimitedNov 14, 2025
483 Immacule Lifesciences Private LimitedSep 18, 2025 · Solan, India
483 Gland Chemicals Private Limited B-11 Plot No B-3, Sipcot Industrial Park & B-6 to B-18Jan 27, 2025 · Chennai, India
483 ExcelvisionNov 19, 2024 · Annonay, France

About this profile

What does Angelica M. Hernandez inspect?

Angelica M. Hernandez appears on 15 documents on file covering 13 sites, most often in India.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Angelica M. Hernandez is dated Mar 10, 2026.